EUVIMEDEUVIMED entdecken
Open Access

Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States

Nikita Sandeep Wagle, Sulki Park, David Washburn, Robert L Ohsfeldt, Nicole E Rich, Amit G Singal, Hye-Chung Kum

Clinical Gastroenterology and Hepatology · 2023-05 · 21 (5) · 1281-1292.e10

DOI: 10.1016/j.cgh.2022.07.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-05. Verfasst von Nikita Sandeep Wagle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Population Informatics Lab, Texas A&M University, College Station, Texas; Department of Health Policy & Management, School of Public Health, Texas A&…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIMHD NIH HHS, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Failures have been reported across the cancer care continuum in patients with hepatocellular carcinoma (HCC); however, the impact of treatment delays on outcomes has not been well-characterized. We described the prevalence of treatment delays in a racially and ethnically diverse cohort of patients and its association with overall survival. METHODS: Using the Surveillance, Epidemiology, and End Results-Medicare database, we identified patients diagnosed with HCC between 2001 and 2015. We performed multivariable logistic regression analysis to identify factors associated with treatment delay (ie, receipt of HCC-directed therapy >3 months after diagnosis). Cox proportional hazards regression analysis with a 5-month landmark was used to characterize the association between treatment delay and overall survival, accounting for immortal time bias. RESULTS: Of 8450 patients with treatment within 12 months of HCC diagnosis, 1205 (14.3%) experienced treatment delays. The proportion with treatment delays ranged from 6.8% of patients undergoing surgical resection to 21.6% of those undergoing liver transplantation. In multivariable analysis, Black patients (odds ratio, 1.96; 95% confidence interval [CI], 1.21-3.15) and those living in high poverty neighborhoods (odds ratio, 1.55; 95% CI, 1.25-1.92) were more likely to experience treatment delays than white patients and those living in low poverty neighborhoods, respectively. Treatment delay was independently associated with worse survival (hazard ratio 1.15, 95% CI, 1.05-1.25). CONCLUSIONS: Nearly 1 in 7 patients with HCC experience treatment delays, with higher odds in Black patients and those living in high poverty neighborhoods. Treatment delays are associated with worse survival, highlighting a need for interventions to improve time-to-treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansAgedUnited StatesTime-to-TreatmentSocioeconomic Disparities in HealthMedicareRetrospective StudiesSEER Program

Stichwörter der Autor:innen

InequityLiver CancerPrognosisSurvivalTreatment

Autor:innen und Institutionen

  • Population Informatics Lab, Texas A&M University, College Station, Texas; Department of Health Policy & Management, School of Public Health, Texas A&M Health Science Center, College Station, Texas.
  • Population Informatics Lab, Texas A&M University, College Station, Texas; Department of Industrial & Systems Engineering, Texas A&M University, College Station, Texas.
  • Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas.
  • Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas. Electronic address: amit.singal@utsouthwestern.edu.
  • Population Informatics Lab, Texas A&M University, College Station, Texas; Department of Health Policy & Management, School of Public Health, Texas A&M Health Science Center, College Station, Texas; Department of Industr…

Förderung

  • NCI NIH HHS
  • NIMHD NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health

Zitieren

APA

Wagle, N. S., Park, S., Washburn, D., Ohsfeldt, R. L., Rich, N. E., Singal, A. G., & Kum, H. C. (2023). Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology, 21(5), 1281-1292.e10. https://doi.org/10.1016/j.cgh.2022.07.031

Vancouver

Wagle NS, Park S, Washburn D, Ohsfeldt RL, Rich NE, Singal AG, et al. Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology. 2023;21(5):1281-1292.e10. doi:10.1016/j.cgh.2022.07.031

BibTeX
@article{Wagle2023,
  author = {Wagle, Nikita Sandeep and Park, Sulki and Washburn, David and Ohsfeldt, Robert L and Rich, Nicole E and Singal, Amit G and Kum, Hye-Chung},
  title = {Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {5},
  pages = {1281--1292.e10},
  doi = {10.1016/j.cgh.2022.07.031}
}
Kostenlos starten →